Captopril and its time of administration in myocardial ischaemic-reperfusion injury

Author： Maulik S.K.   Kumari R.   Maulik M.   Manchanda S.C.   Gupta S.K.  

Publisher： Academic Press

ISSN： 1043-6618

Source： Pharmacological Research, Vol.44, Iss.2, 2001-08, pp. : 123-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of post-ischaemic inflammation as a therapeutic approach to myocardial ischaemia reperfusion injury

By Kupatt C.   Wichels R.   Becker B.   Boekstegers P.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1395-1404

Informa Healthcare

Access to resources Recommend Favorite

The Myocardial Na/H Exchanger: A Potential Therapeutic Target for the Prevention of Myocardial Ischaemic and Reperfusion Injury and Attenuation of Postinfarction Heart Failure

By Karmazyn M.   Sostaric J.V.   Gan X.T.  

Drugs, Vol. 61, Iss. 3, 2001-01 ,pp. : 375-389

Adis International

Access to resources Recommend Favorite

Effects of captopril and losartan on myocardial ischemia–reperfusion induced arrhythmias and necrosis in rats

By Ozer M.K.   Sahna E.   Birincioglu M.   Acet A.  

Pharmacological Research, Vol. 45, Iss. 4, 2002-04 ,pp. : 257-263

Academic Press

Access to resources Recommend Favorite

Prevention of Cell Damage in Ischaemic-Reperfusion: Mitochondrial Respiratory Chain as a Pharmacological Target

By  

Letters in Drug Design & Discovery, Vol. 1, Iss. 3, 2004-07 ,pp. : 279-284

Bentham Science Publishers

Access to resources Recommend Favorite

Endoxin Antagonist Lessens Myocardial Ischemia Reperfusion Injury

By Ke Yong-Sheng   Wang De-Guo   Wang   He-Gui   Yang Shang-Yin  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 4, 2004-07 ,pp. : 289-293

Springer Publishing Company

Access to resources Recommend Favorite